hero-line-left hero-line-top

Press releases

hero-line-bottom
hero-line-horizontal
temp-hero-icon

Syapse Raises $30 Million to Expand Access to Precision Oncology

San Francisco, Calif. (November 14, 2017) – Syapse, a leader in precision medicine solutions, has raised $30 million in Series D financing,…

Read

Aurora Cancer Care Teams With Syapse to Launch Precision Medicine Program to Bring Greater Cancer Treatment Options to Patients

Milwaukee, Wis. – Aurora Cancer Care and Syapse, a market leader in precision oncology solutions, have teamed to launch…

Read

Sylvester Comprehensive Cancer Center Partners with Syapse to Launch New Precision Medicine Initiative

Miami, Fla. (April 5, 2017) – Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, and Syapse, a…

Read

Precision Medicine Leader Syapse Announces Ken Tarkoff as New CEO

Palo Alto, Calif. (March 15, 2017) – Syapse, a market leader in precision oncology solutions, announced today that Ken Tarkoff is joining th…

Read

Dignity Health and Catholic Health Initiatives Team Up to Launch the Largest Community-Based Precision Medicine Program in the U.S.

SAN FRANCISCO, Calif. and ENGLEWOOD, Colo., September 19, 2016 – Dignity Health and Catholic Health Initiatives (CHI), t…

Read

Henry Ford Health System and Syapse Partner to Launch Cancer Precision Medicine Program

WASHINGTON, D.C., June 29, 2016 - Henry Ford Health System, one of the nation’s leading comprehensive and integrated health system…

Read

Catholic Health Initiatives and Syapse Launch National Cancer Precision Medicine Program

WASHINGTON, D.C.; PALO ALTO, Calif.; ENGLEWOOD, Colo., June 29, 2016 - Catholic Health Initiatives (CHI), the nation’s second-largest nonpro…

Read

Oncology Precision Network (OPeN) Announces Data Sharing Commitments at Vice President Biden’s Cancer Moonshot Summit

PALO ALTO, Calif.; SALT LAKE CITY, Utah; RENTON, Wash.; STANFORD, Calif., June 29, 2016 - An initiative to end cancer is getting a boost fro…

Read

TAPUR Study Achieves Milestones: Forty-Nine Patients Consent to Participate, Bayer and Merck Sign on as Drug Providers, and Thirty-Seven Sites Are Participating Twelve Weeks Post-Launch

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) announced today that Bayer and Merck are the most recent companies t…

Read

Pioneering Data-Sharing Network Created to Accelerate Cancer Precision Medicine Development

PALO ALTO, Calif.; SALT LAKE CITY, Utah; RENTON, Wash.; STANFORD, Calif., June 2, 2016 - Intermountain Healthcare, Stanford Cancer Inst…

Read

ASCO Kicks off Ground-Breaking Clinical Trial to Learn from Use of Approved Targeted Cancer Therapies Matched to Tumor Genomics

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced it has begun recruiting patients with advanced cancer for…

Read

White House Recognizes Intermountain Healthcare and Syapse for Their Commitment to Precision Medicine

SALT LAKE CITY, Utah and PALO ALTO, Calif., February 26, 2016 – On February 25th, leaders from Intermountain Healthcare, a not-for-profit he…

Read

Syapse Launches Global Partner Program

PALO ALTO, Calif., February 18, 2016 – Syapse, the leader in precision medicine software, announced today the creation of the Syapse Global…

Read

Syapse Raises $25 Million Series C Round Led by Ascension Ventures to Expand Precision Medicine

PALO ALTO, Calif. and CLAYTON, Mo., January 12, 2016 – Syapse, the leader in precision medicine software, has completed the first close of a…

Read

Caris Life Sciences and Syapse Collaborate to Aggregate Oncology Data that Will Power Precision Medicine and Improve Patient Care

IRVING, Texas and PALO ALTO, Calif., November 18, 2015 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the pro…

Read

A Groundbreaking Global Alliance Forms to Find Effective Response to the Deadliest Human Brain Tumor

A message from Jonathan Hirsch, Syapse Founder & President: “Each year, tens of thousands of people around the world will receive a diagnos…

Read

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

ST. LOUIS, Mo. and PALO ALTO, Calif., October 29, 2015 – PierianDx, makers of the leading bioinformatics platform for clinical genomics test…

Read

Syapse Precision Medicine Platform Selected by Leading Oncology Society to Enable Targeted Agent and Profiling Utilization Registry (TAPUR) Study

PALO ALTO, Calif., June 1, 2015 – Syapse, the leading provider of precision medicine software, announced today that its Syapse Precision Med…

Read

ASCO Launches First-Ever Clinical Trial: Aims to Learn from Patients with Advanced Cancer Who Lack Standard Treatment Options

Five Leading Pharmaceutical Companies Will Support Innovative Study, Contribute Drugs CHICAGO, Ill., June 1, 2015 – The American Society of…

Read

New Studies by Intermountain Healthcare’s Intermountain Precision Genomics Reveal that Precision Medicine Improves Survival in Advanced Cancer Patients without Increasing Costs

SALT LAKE CITY, Utah, May 29, 2015 – Two new studies conducted by Intermountain Healthcare’s Intermountain Precision Gen…

Read

Syapse Featured on Opening Bell with Maria Bartiromo

Our own Founder & President Jonathan Hirsch appeared this morning on Fox Business’ Opening Bell with Maria Bartiromo to discuss how Syapse i…

Read